You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens
|
|---|---|
| Published in |
Breast Cancer Research and Treatment, April 2021
|
| DOI | 10.1007/s10549-021-06217-4 |
| Pubmed ID | |
| Authors |
Beverly Moy, Mafalda Oliveira, Cristina Saura, William Gradishar, Sung-Bae Kim, Adam Brufsky, Sara A. Hurvitz, Larisa Ryvo, Daniele Fagnani, Sujith Kalmadi, Paula Silverman, Suzette Delaloge, Jesus Alarcon, Ava Kwong, Keun Seok Lee, Peter Cher Siang Ang, Samuel Guan Wei Ow, Sung-Chao Chu, Richard Bryce, Kiana Keyvanjah, Judith Bebchuk, Bo Zhang, Nina Oestreicher, Ron Bose, Nancy Chan |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 75% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 45 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 6 | 13% |
| Student > Bachelor | 3 | 7% |
| Professor | 2 | 4% |
| Student > Master | 2 | 4% |
| Student > Postgraduate | 2 | 4% |
| Other | 5 | 11% |
| Unknown | 25 | 56% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 7% |
| Biochemistry, Genetics and Molecular Biology | 2 | 4% |
| Nursing and Health Professions | 2 | 4% |
| Psychology | 1 | 2% |
| Other | 3 | 7% |
| Unknown | 28 | 62% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 June 2021.
All research outputs
#3,770,445
of 23,308,124 outputs
Outputs from Breast Cancer Research and Treatment
#664
of 4,707 outputs
Outputs of similar age
#90,852
of 437,600 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#18
of 78 outputs
Altmetric has tracked 23,308,124 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,707 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,600 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 78 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.